PLoS ONE (Jan 2014)

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World.

  • Emanuela Foglia,
  • Paolo Bonfanti,
  • Giuliano Rizzardini,
  • Erminio Bonizzoni,
  • Umberto Restelli,
  • Elena Ricci,
  • Emanuele Porazzi,
  • Francesca Scolari,
  • Davide Croce

DOI
https://doi.org/10.1371/annotation/e57d7e73-826c-4e1c-a7c6-d2c32d3809af
Journal volume & issue
Vol. 9, no. 1

Abstract

Read online

No abstracts available.